GENOME ANNOUNCEMENT
===================

The Centers for Disease Control and Prevention classifies whooping cough as a reemerging disease, documenting increasing numbers of cases nearly every year, from hundreds per year in the 1970s to \>41,000 in 2012 ([@B1]). The recent high-profile epidemics in California (in 2010) and Washington (in 2012) contribute to growing concerns and feed speculation about the ongoing evolution of *Bordetella pertussis*. To address these concerns, we collected 28 strains of *B. pertussis* from these and other outbreaks and made them available at the Biodefense and Emerging Infections Research Resources Repository for further study by others.

Here, we report the genome sequences of these 28 clinical isolates derived from whooping cough hospital cases that occurred between 2010 and 2012. Genomic DNA was prepared using a phenol-chloroform extraction method and ethanol precipitation ([@B2]). A combination of 3- or 5-kb mate pair (\~30× coverage) and 100-bp Illumina paired-end reads (\~50× coverage) were used for genome sequence determination. After quality trimming, all reads were used to generate assemblies with Celera assembler 6.1 ([@B3]) or Velvet assembler ([@B4]). After improvement, all genomes had between 4 and 186 scaffolds containing 25 to 285 contigs. Underlying consensus sequences and gaps were improved using custom scripts developed at the J. Craig Venter Institute (JCVI). The overall G+C content in all cases was \~67%, with genome sizes ranging from 3.83 Mb to 4.15 Mb (average, 4.0 Mb). Up to 218 copies of insertion element IS*481* and 95 tripartite transcarboxylate transporter (TTT) element were found in any one *B. pertussis* genome, amounting to \>215 kb on average. All of the *B. pertussis* isolates, irrespective of geographic location, belong to the same multilocus sequence type and are nearly identical to each other at the protein level (average 99% identity) in conserved regions of the chromosome. However, the *B. pertussis* genomes were subject to massive genome rearrangements and different gene losses that account for the majority of the diversity between strains. All the genomes were annotated using JCVI's annotation pipeline (<http://www.jcvi.org>) and were predicted to have between 3,750 and 4,193 genes. As expected, mobile elements were overrepresented in these genomes compared to in published *Bordetella bronchiseptica* genomes due to the expansion of the repetitive elements. Over 1,000 core *B. bronchiseptica* genes were absent in all of the *B. pertussis* genomes. Many of these genes are involved in capsule biosynthesis, alternate respiration, nutrient acquisition, type VI secretion, and antibiotic resistance. All *B. pertussis* isolates encoded pertussis toxin, filamentous hemagglutinin, type III secretion system, adenylate cyclase, and other virulence factors.

The findings from this study suggest that currently circulating *B. pertussis* isolates in the United States are derived from a single genetic background. A full analysis of the virulence genes and evolution of *B. pertussis* is under way and will be published in a subsequent report.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The *B. pertussis* whole-genome shotgun projects have been deposited for each isolate at DDBJ/EMBL/GenBank as described in [Table 1](#tab1){ref-type="table"}. The version described in this paper is the first version.

###### 

Characteristics of the 28 *B. pertussis* strains

  *B. pertussis* strain name   NCBI accession no.                                                      No. of contigs   N~50~ (bp)   Total length (bp)   G+C %
  ---------------------------- ----------------------------------------------------------------------- ---------------- ------------ ------------------- -------
  2250905                      [AXSU00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSU00000000)   285              20,908       3,940,180           67.76
  2356847                      [AXST00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXST00000000)   179              31,198       3,907,019           67.86
  2371640                      [AXSS00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSS00000000)   193              33,462       3,904,605           67.88
  STO1-SEAT-0006               [AXSR00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSR00000000)   49               139,362      4,028,421           67.77
  STO1-SEAT-0007               [AXSQ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSQ00000000)   26               343,155      4,053,851           67.78
  STO1-CHLA-0011               [AXSP00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSP00000000)   25               419,274      4,083,349           67.69
  H897                         [AXSO00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSO00000000)   173              36,602       3,938,675           67.81
  H918                         [AXSN00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSN00000000)   60               150,397      4,073,712           67.71
  H921                         [AXSM00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSM00000000)   48               164,785      4,064,086           67.73
  H939                         [AXSL00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSL00000000)   43               177,196      4,018,810           67.74
  H973                         [AXSK00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSK00000000)   62               112,367      4,014,250           67.81
  STO1-SEAT-0004               [AXSJ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSJ00000000)   121              52,170       3,839,596           67.9
  I002                         [AXSI00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSI00000000)   63               102,522      4,047,567           67.74
  I036                         [AXSH00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSH00000000)   46               189,616      4,057,285           67.74
  I176                         [AXSG00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSG00000000)   33               266,526      4,045,246           67.78
  STO1-CHLA-0006               [AXSF00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSF00000000)   65               134,387      4,044,283           67.79
  CHLA-15                      [AXSD00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSD00000000)   138              46,158       3,844,206           67.89
  CHLA-13                      [AXSE00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSE00000000)   95               74,009       4,029,822           67.79
  CHLA-20                      [AXSC00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSC00000000)   131              46,140       3,828,499           67.9
  CHLA-26                      [AXSB00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSB00000000)   41               264,509      4,045,408           67.8
  STO1-CHOC-0016               [AXSA00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSA00000000)   54               122,855      4,033,849           67.79
  STO1-CHOC-0017               [AXRZ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRZ00000000)   108              45,197       4,050,208           67.8
  STO1-CHOC-0018               [AXRY00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRY00000000)   127              43,391       4,051,577           67.81
  STO1-CHOC-0019               [AXRX00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRX00000000)   120              52,255       4,150,262           67.72
  STO1-CHOC-0021               [AXRW00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRW00000000)   56               115,723      4,027,480           67.8
  STO1-CHOC-0008               [AXRV00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRV00000000)   124              50,507       3,834,602           67.9
  STO1-CHOM-0012               [AXRU00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXRU00000000)   37               222,972      4,065,443           67.71
  STO1-CNMC-0004               [AXSV00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AXSV00000000)   149              46,159       3,855,042           67.88
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